LU87161A1 - Compositions pharmaceutiques - Google Patents

Compositions pharmaceutiques Download PDF

Info

Publication number
LU87161A1
LU87161A1 LU87161A LU87161A LU87161A1 LU 87161 A1 LU87161 A1 LU 87161A1 LU 87161 A LU87161 A LU 87161A LU 87161 A LU87161 A LU 87161A LU 87161 A1 LU87161 A1 LU 87161A1
Authority
LU
Luxembourg
Prior art keywords
composition according
skin
composition
pharmaceutically acceptable
propyl
Prior art date
Application number
LU87161A
Other languages
English (en)
French (fr)
Inventor
Joseph Wilson Dr Totten
Kenneth Andrew Dr Walters
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878706242A external-priority patent/GB8706242D0/en
Priority claimed from GB888800833A external-priority patent/GB8800833D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of LU87161A1 publication Critical patent/LU87161A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LU87161A 1987-03-17 1988-03-16 Compositions pharmaceutiques LU87161A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878706242A GB8706242D0 (en) 1987-03-17 1987-03-17 Formulation
GB8706242 1987-03-17
GB8800833 1988-01-14
GB888800833A GB8800833D0 (en) 1988-01-14 1988-01-14 Formulation

Publications (1)

Publication Number Publication Date
LU87161A1 true LU87161A1 (fr) 1988-08-23

Family

ID=26292020

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87161A LU87161A1 (fr) 1987-03-17 1988-03-16 Compositions pharmaceutiques

Country Status (10)

Country Link
US (1) US4868192A (pt)
EP (1) EP0294914A3 (pt)
BE (1) BE1002182A5 (pt)
CH (1) CH675356A5 (pt)
DK (1) DK143188A (pt)
FR (1) FR2612397A1 (pt)
GB (1) GB2202145B (pt)
GR (1) GR880100159A (pt)
LU (1) LU87161A1 (pt)
PT (1) PT86998B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38628E1 (en) * 1986-12-23 2004-10-19 Fisons Plc Pharmaceutical compositions
DE3787274T2 (de) * 1986-12-23 1994-01-27 Fisons Plc Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten.
US5198221A (en) * 1989-05-17 1993-03-30 Fisons Plc Pharmaceutical composition
GB8911259D0 (en) * 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
US5686095A (en) * 1995-10-23 1997-11-11 Price, Jr.; Francis W. Method of treating canker sores
GB9810949D0 (en) 1998-05-22 1998-07-22 Hewlett Healthcare Limited Formulation
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6861442B1 (en) * 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
PL2526930T3 (pl) * 2005-06-01 2014-05-30 Glaxosmithkline Ip Dev Ltd Formulacja witaminowa
GB2587402B (en) 2019-09-27 2023-05-10 Hewlett Healthcare Ltd Formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA782473B (en) * 1977-05-04 1979-04-25 Fisons Ltd Benzo pyrano-quinolinones
US4474787A (en) * 1977-05-04 1984-10-02 Fisons Limited 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
EP0162556B1 (en) * 1984-04-13 1991-11-06 FISONS plc Novels forms and formulations of nedocromil sodium
GB2187953B (en) * 1986-03-15 1989-11-15 Fisons Plc Pharmaceutical formulation
GB8630419D0 (en) * 1986-12-19 1987-01-28 Fisons Plc Pharmaceutical formulation
DE3787274T2 (de) * 1986-12-23 1994-01-27 Fisons Plc Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten.

Also Published As

Publication number Publication date
GB2202145A (en) 1988-09-21
PT86998A (pt) 1988-04-01
GB2202145B (en) 1991-01-02
CH675356A5 (pt) 1990-09-28
DK143188A (da) 1988-09-18
US4868192A (en) 1989-09-19
BE1002182A5 (fr) 1990-10-02
GB8804697D0 (en) 1988-03-30
GR880100159A (el) 1989-01-31
EP0294914A3 (en) 1990-10-10
PT86998B (pt) 1992-06-30
EP0294914A2 (en) 1988-12-14
DK143188D0 (da) 1988-03-16
FR2612397A1 (fr) 1988-09-23

Similar Documents

Publication Publication Date Title
FR2482456A1 (fr) Composition en gel, anti-inflammatoire et analgesique, a base de ketoprofene et/ou de flurbiprofene
FR2848112A1 (fr) Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations
EP2105165A2 (fr) Composition cosmétique comprenant un dérivé d'acide imido-percarboxylique et un ester n-acylé d'acide aminé
FR2500301A1 (fr) Cataplasmes analgesiques anti-inflammatoires et leur procede de production
LU87161A1 (fr) Compositions pharmaceutiques
JP2001517621A (ja) 局所用非ステロイド系抗炎症剤組成物
FR2850023A1 (fr) Medicaments pour le systeme nerveux
BE1007024A5 (fr) Compositions a activite agoniste des recepteurs analogues a 5ht1, selective.
CA2013557A1 (fr) Compositions cosmetiques et pharmaceutiques contenant des derives lipophiles du benzylidene camphre et nouveaux derives lipophiles du benzylidene camphre
EP0243248A1 (fr) Compositions pour le traitement de la calvitie et des alopécies
JP2003505415A (ja) 皮膚、粘膜、器官または組織の疾患を治療するためのトシルクロルアミドの使用
EP0387314B1 (fr) Utilisation d'agent actif contre les retrovirus et produits ainsi mis en uvre
EP0465313B1 (fr) Composition cicatrisante à usage local
LU87033A1 (fr) Nouvelle association medicamenteuse
EP0197876B1 (fr) Composition thérapeutique utilisable en dermatologie contenant de l'imidazolidinylurée comme principe actif
EP0966276A1 (fr) Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants
LU84893A1 (fr) Composition pharmaceutique
FR2853245A1 (fr) Utilisation du quinquina pour la preparation d'un medicament stimulant l'angiogenese
JP2516477B2 (ja) 皮膚の血行不良に起因する疾患の治療剤
FR2619010A1 (fr) Composition pharmaceutique antivirale comprenant de la 5-isopropyl-2'-b-deoxyuridine, s'accumulant dans la peau, applicable par voie externe et procede pour sa preparation
FR2858227A1 (fr) Utilisation cosmetique d'un derive de biguanide en tant qu'actif anti-vieillissement de la peau
FR2507891A1 (fr) Medicament, notamment pour le traitement des maladies a virus du type herpes
FR2648350A1 (fr) Utilisation de lipopolysaccharides extraits de bacteries gram(-) pour la fabrication d'un medicament facilitant la cicatrisation de la peau
FR2650502A1 (fr) Nouvelle forme galenique orale ameliorant la biodisponibilite
CA2524092A1 (fr) Composition et utilisation de l'iode pur dissout dans l'huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia